AIM: To validate the 'Prueba Cognitiva de Leganés' (PCL) as a screening tool for cognitive impairment in elderly people with little formal education. METHODS: The PCL is a simple cognitive test with 32 items that includes two scores of orientation and memory and a global score of 0-32 points. It was applied to a population sample of 527 elderly people over 70 with low educational level, who were independently diagnosed by consensus between two neurologists as having normal cognitive function, age associated cognitive decline (AACD, IPA-OMS criteria) or dementia (DSM-IV criteria). Individuals with severe visual or hearing defects and those who rejected the exam were excluded from the study. The PCL was validated in a sample of 375 individuals: 300 normal, 42 with AACD and 33 with dementia. The sensitivity, specificity, accuracy and likelihood ratios, as well as the ROC curves for dementia and for AACD-dementia, were calculated. The confounding effect of sociodemographic variables was assessed by logistic regression analysis and convergent validity by partial correlations of the PCL with other cognitive tests. Inter-rater reliability was evaluated with the intraclass correlation coefficient. RESULTS: The PCL identified dementia (cut-off < or =22) and AACD-dementia (cut-off < or =26), with the following diagnostic parameters, respectively: sensitivity 93.9%-80%, specificity 94.7%-84.3%, positive likelihood ratio 17.8-5.1, negative likelihood ratio 0.06-0.24, and accuracy 94.6%-83.4%. The areas under the ROC curve were 0.985 (95% Confidence Intervals (CI) 0.967-0.995) and 0.904 (95% CI: 0.870-0.932) respectively. The intraclass correlation coefficient was 0.79 (0.74-0.83). CONCLUSION: The PCL is a simple instrument, which is both valid and reliable, for the screening of dementia in population samples of individuals with low educational level. This instrument could be useful in primary health care. Copyright 2003 John Wiley & Sons, Ltd.
AIM: To validate the 'Prueba Cognitiva de Leganés' (PCL) as a screening tool for cognitive impairment in elderly people with little formal education. METHODS: The PCL is a simple cognitive test with 32 items that includes two scores of orientation and memory and a global score of 0-32 points. It was applied to a population sample of 527 elderly people over 70 with low educational level, who were independently diagnosed by consensus between two neurologists as having normal cognitive function, age associated cognitive decline (AACD, IPA-OMS criteria) or dementia (DSM-IV criteria). Individuals with severe visual or hearing defects and those who rejected the exam were excluded from the study. The PCL was validated in a sample of 375 individuals: 300 normal, 42 with AACD and 33 with dementia. The sensitivity, specificity, accuracy and likelihood ratios, as well as the ROC curves for dementia and for AACD-dementia, were calculated. The confounding effect of sociodemographic variables was assessed by logistic regression analysis and convergent validity by partial correlations of the PCL with other cognitive tests. Inter-rater reliability was evaluated with the intraclass correlation coefficient. RESULTS: The PCL identified dementia (cut-off < or =22) and AACD-dementia (cut-off < or =26), with the following diagnostic parameters, respectively: sensitivity 93.9%-80%, specificity 94.7%-84.3%, positive likelihood ratio 17.8-5.1, negative likelihood ratio 0.06-0.24, and accuracy 94.6%-83.4%. The areas under the ROC curve were 0.985 (95% Confidence Intervals (CI) 0.967-0.995) and 0.904 (95% CI: 0.870-0.932) respectively. The intraclass correlation coefficient was 0.79 (0.74-0.83). CONCLUSION: The PCL is a simple instrument, which is both valid and reliable, for the screening of dementia in population samples of individuals with low educational level. This instrument could be useful in primary health care. Copyright 2003 John Wiley & Sons, Ltd.
Authors: Á Sánchez-Ferro; J Benito-León; E D Louis; I Contador; J Hernández-Gallego; V Puertas-Martín; F Bermejo-Pareja Journal: Acta Neurol Scand Date: 2017-03-05 Impact factor: 3.209
Authors: B Doulougou; F Gomez; B Alvarado; R O Guerra; A Ylli; J Guralnik; M V Zunzunegui Journal: J Hum Hypertens Date: 2015-04-02 Impact factor: 3.012
Authors: Mohammad Auais; Beatriz Alvarado; Ricardo Guerra; Carmen Curcio; Ellen E Freeman; Alban Ylli; Jack Guralnik; Nandini Deshpande Journal: Age Ageing Date: 2017-05-01 Impact factor: 10.668
Authors: Oscar H Del Brutto; Perla Salgado; Julio Lama; Victor J Del Brutto; Xavier Campos; Mauricio Zambrano; Héctor H García Journal: Am J Trop Med Hyg Date: 2014-10-27 Impact factor: 2.345
Authors: Phoebe W Hwang; Cristiano Dos Santos Gomes; Mohammad Auais; Kathryn L Braun; Jack M Guralnik; Catherine M Pirkle Journal: J Aging Health Date: 2017-10-18
Authors: Tamer Ahmed; Emmanuelle Belanger; Afshin Vafaei; Georges K Koné; Beatriz Alvarado; François Béland; Maria Victoria Zunzunegui Journal: J Cross Cult Gerontol Date: 2018-03
Authors: Carmen-Lucia Curcio; Yan Yan Wu; Afshin Vafaei; Juliana Fernandez de Souza Barbosa; Ricardo Guerra; Jack Guralnik; Fernando Gomez Journal: J Gerontol A Biol Sci Med Sci Date: 2020-01-01 Impact factor: 6.053